Company news
Inotiv, Inc. news in 2022
Inotiv, Inc.'s news releases, calls and decks from 2022, newest first.
Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results
December 11, 2022
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 7, 2022
Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process
November 28, 2022
Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022
November 27, 2022
Inotiv, Inc. Announces Third Quarter Fiscal 2022 Financial Results
August 9, 2022
Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville, MD, Location
July 25, 2022
Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Protypia, Inc.
July 6, 2022
Glenn Washer Joins Inotiv, Inc., as Group President, Safety Assessment
June 21, 2022
Inotiv, Inc. Announces Site Closures and Consolidation Plans
June 12, 2022
Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results
May 11, 2022
Inotiv, Inc. Bolsters Pathology Services with Acquisition of Histion, LLC
April 24, 2022
Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results
February 9, 2022
Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc.
January 26, 2022
Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC
January 9, 2022
Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. (“RSI”)
January 5, 2022
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
January 3, 2022